NovoCure Ltd. (NVCR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about NovoCure Ltd. (NVCR)
Go deeper and ask any question about NVCR
Company Performance
Current Price
as of Sep 13, 2024$18.57
P/E Ratio
N/A
Market Cap
$2.01B
Description
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Metrics
Overview
- HQSt. Helier, JE
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNVCR
- Price$18.57+7.16%
Trading Information
- Market Cap$2.01B
- Float90.11%
- Average Daily Volume (1m)1,068,334
- Average Daily Volume (3m)1,410,351
- EPS-$1.57
Company
- Revenue$549.96M
- Rev Growth (1yr)19.28%
- Net Income-$33.38M
- Gross Margin76.95%
- EBITDA Margin-20.45%
- EBITDA-$30.75M
- EV$1.57B
- EV/Revenue2.85
- P/EN/A
- P/S3.64
Documents
SEC Filings
Earnings Calls
Factset Street Account